In what Hollywood hopes is a good start to what will be a strong month at the box office, Sony’s Morbius earned $5.7 million in Thursday previews.
In what Hollywood hopes is a good start to what will be a strong month at the box office, Sony’searned $5.7 million in Thursday previews. The next chapter in the uh, Sony Pictures Universe of Marvel Characters, stars Jared Leto as “the living vampire” who turns himself into a bloodsucker in an attempt to cure a lifelong blood disease.
The Daniel Espinosa-directed film was supposed to open two summers ago with the first trailer debuting in early January of 2020. The sheer unending run oftrailers playing before almost every single theatrical motion picture since at least March of 2021 became its own running joke. Pour one out for never, ever having to see the trailer forYes, the reviews were terrible with 15% rotten and 3.4/10 on Rotten Tomatoes.
Anyway, I’ll refrain from further commentary until I see the film, but its $75 million budget is another example of Sony’s recent run of “blockbusters on a budget” tentpoles that don’t require record-breaking grosses to cross into profitability.Venom: Let There Be Carnage then it’ll score $45 million for the weekend. Worst case scenario is that audiences don’t like it much more than critics and that it ends up with a Thursday-to-weekend figure on par withThe “realistic” best-case scenario is a straight-up “normal for Marvel” 9% to 12% split, giving the film a debut between $48 million and $63 million. Splitting the difference givesVenom
as Eddie Brock is more popular than Michael Morbius and Tom Hardy is more popular than Jared Leto. But since Sony spent 17% less on